<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701777</url>
  </required_header>
  <id_info>
    <org_study_id>B1807-R</org_study_id>
    <secondary_id>20151115</secondary_id>
    <nct_id>NCT02701777</nct_id>
  </id_info>
  <brief_title>Enhancing STDP After Spinal Cord Injury</brief_title>
  <official_title>Maximizing Spike - Timing Dependent Plasticity After Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal is to develop new clinical approaches to restore upper-limb function after
      incomplete cervical spinal cord injury (SCI). Corticospinal tract (CST) axons are involved in
      controlling upper-limb function. Paired pulse induced spike-timing dependent plasticity
      (STDP) enhances synaptic strength between residual CST axons and spinal motoneurons (SMNs)
      resulting in temporary improvements in upper-limb function in humans with incomplete cervical
      SCI. Motor training will be combined with paired-pulse STDP stimulation to further enhance
      plasticity and behavioral recovery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Magnetic Stimulation and electrical stimulation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>participants will not know if they receive real or sham stimulation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in amplitude of Motor evoked potential size</measure>
    <time_frame>post treatment at minute 0, minute 10, minute30, minute 60.</time_frame>
    <description>at the stated minute interval measurements are reassessed to effect</description>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>STDP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>paired stimulation will be given to the brain so that the messages are received at the spinal cord at the correct time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STDP+ Seromycin/ Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a single dose of 100mg of Seromycin will be given in a pill form by mouth and then paired stimulation will be applied to the brain so that the messages are received at the spinal cord at the correct time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STDP+Dextromethorphan/ Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a single dose of 150mg of Dextromethorphan will be given in a pill form by mouth and then paired stimulation (STDP) will be applied to the brain so that the messages are received at the spinal cord at the correct time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training +STDP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>motor training exercises will be done repetitively and then stimulation (STDP) to the brain will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>motor training exercises will be done repetitively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training + Seromycin+STDP/ Sham STDP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Motor Training will be completed, then a single dose of 100 mg of Seromycin will be administered in pill form, and then stimulation or sham stimulation will be applied to the brain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham STDP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fake stimulation will be given to the brain so that the messages are received at the spinal cord at the correct time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Seromycin</intervention_name>
    <description>100mg pill of Seromycin by mouth will be administered</description>
    <arm_group_label>STDP+ Seromycin/ Placebo</arm_group_label>
    <arm_group_label>Training + Seromycin+STDP/ Sham STDP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STDP</intervention_name>
    <description>noninvasive magnetic or electrical stimulation will be applied to the brain</description>
    <arm_group_label>STDP</arm_group_label>
    <arm_group_label>STDP+ Seromycin/ Placebo</arm_group_label>
    <arm_group_label>STDP+Dextromethorphan/ Placebo</arm_group_label>
    <arm_group_label>Training +STDP</arm_group_label>
    <arm_group_label>Training + Seromycin+STDP/ Sham STDP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training</intervention_name>
    <description>following the directions of the researcher the participant will be asked to perform specific repetitive movements using their hand, arm or leg .</description>
    <arm_group_label>Training +STDP</arm_group_label>
    <arm_group_label>Training</arm_group_label>
    <arm_group_label>Training + Seromycin+STDP/ Sham STDP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextromethorphan</intervention_name>
    <description>150mg of DExtromethorphan pill will be administered</description>
    <arm_group_label>STDP+Dextromethorphan/ Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Seromycin Placebo</intervention_name>
    <description>placebo pill will be administered</description>
    <arm_group_label>STDP+ Seromycin/ Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextromethorphan Placebo</intervention_name>
    <description>placebo pill will be administered</description>
    <arm_group_label>STDP+Dextromethorphan/ Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham STDP</intervention_name>
    <description>noninvasive magnetic or electrical sham stimulation will be applied to the brain</description>
    <arm_group_label>Sham STDP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants who are unimpaired healthy controls:

          -  Male and females between ages 18-85 years

          -  Right handed

          -  Able to complete precision grips with both hands

          -  Able to complete full wrist flexion-extension bilaterally

          -  Able to walk unassisted

          -  Able to complete full ankle flexion-extension bilaterally

        Participants who have had a spinal cord injury:

          -  Male and females between ages 18-85 years

          -  SCI ( 2 months of injury)

          -  Spinal Cord injury at or above L5

          -  The ability to produce a visible precision grip force with one hand

          -  Able to perform some small wrist flexion and extension

          -  The ability to perform a small visible contraction with dorsiflexion and hip flexor
             muscles

          -  No subjects will be excluded based on their race, religion, ethnicity, gender or HIV
             status.

          -  ASIA A,B,C, or D

        Exclusion Criteria:

        Exclusion criteria for enrollment For SCI and Healthy Control Subjects (4-8 exclusion for
        non-invasive brain stimulation only):

          -  Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic
             disease

          -  Any debilitating disease prior to the SCI that caused exercise intolerance

          -  Premorbid, ongoing major depression or psychosis, altered cognitive status

          -  History of head injury or stroke

          -  Metal plate in skull

          -  History of seizures

          -  Receiving drugs acting primarily on the central nervous system, which lower the
             seizure threshold (see appendix 2)

          -  Pregnant females

          -  Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal
             cord disease such as spinal stenosis, spina bifida, MS, or herniated disk

          -  Individuals with scalp shrapnel, cochlear implants, or aneurysm clips.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Oudega, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miami VA Healthcare System, Miami, FL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francisco D Benavides, MD</last_name>
    <phone>(305) 575-7000</phone>
    <phone_ext>3179</phone_ext>
    <email>franciscodavid.benavidesjaramillo@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monica A Perez, PhD</last_name>
    <phone>(412) 383-6563</phone>
    <email>perezmo@miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Miami VA Healthcare System, Miami, FL</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco D Benavides, MD</last_name>
      <phone>305-575-7000</phone>
      <phone_ext>3179</phone_ext>
      <email>franciscodavid.benavidesjaramillo@va.gov</email>
    </contact>
    <investigator>
      <last_name>Martin Oudega, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>spike timing dependant plasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dextromethorphan</mesh_term>
    <mesh_term>Cycloserine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

